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OBJECTIVES The purpose of this study was to evaluate the prognostic value of community-based
myocardial perfusion imaging (MPI) and to assess the incremental value of individual
components of 99mTc-sestamibi single photon emission computed tomography (SPECT).
BACKGROUND Although the most rapid growth of MPI has been in community outpatient laboratories, its
prognostic value has not been validated in this setting.
METHODS We prospectively followed 1,612 consecutive patients undergoing stress 99mTc-sestamibi
SPECT in an outpatient community laboratory who experienced 71 hard events over 24 
7 months (0.2% lost to follow-up).
RESULTS Patients whose scans were normal incurred an annualized event rate of 0.4%, compared with
2.3% for those with abnormal scans (p  0.0001). Subset analysis demonstrated comparable
risk stratification for women and men, diabetics, patients with normal resting ECGs, and
those referred for pharmacologic and exercise stress. After adjusting for pre-test variables,
multivariable Cox regression analysis found the most potent independent components of MPI
to be, in order of importance, transient ischemic dilation, extent of reversibility, post-stress
ejection fraction, extent and severity of the stress perfusion defect, and the overall test result
(normal or abnormal). Each 1% decrement of ejection fraction predicted a 3% increase in risk
(p 0.0009). Post-MPI angiography and revascularization increased commensurate with the
extent and severity of MPI result.
CONCLUSIONS The prognostic value of perfusion imaging is portable and transferable to the outpatient
community setting, with multiple components of MPI providing incremental prognostic
information. (J Am Coll Cardiol 2004;43:213–23) © 2004 by the American College of
Cardiology Foundation
The increase in the use of myocardial perfusion imaging
(MPI) in the U.S. over the last decade has been striking.
Myocardial perfusion imaging use increased almost fourfold
between 1992 and 2001—a year in which 7.8 million studies
were performed (1,2). In 2003, an estimated 1 in 15
Americans 40 years or older will undergo MPI. A substan-
tial portion of this growth has been driven by a shift of
performance of MPI from the hospital to the physician’s
office or related outpatient facility. Between 1992 and 2001,
the percentage of all scans performed in the latter setting
increased from 13% to 33%, totaling 2.6 million in 2001
(1,2). The total annual cost of these physicians’ offices and
related outpatient facilities scans currently exceeds $2.5
billion. In addition, of inpatient and outpatient perfusion
imaging performed in a hospital location, 73% of studies are
performed in hospitals with 400 beds, the vast majority of
which would be expected to represent nonteaching, com-
munity hospitals (1). Although the prognostic value of MPI
in academic hospital-based centers has been well docu-
mented (3–7), there is little evidence that similar prognostic
information can be obtained in the community.
Concomitantly, the wide availability of technetium-based
agents and expanded computer processing power has facilitated
the increasing use of gated single photon emission computed
tomography (SPECT). Between 1996 and 2001, the percent-
age of perfusion scans in which ejection fraction (EF) was
obtained increased from 10% (Center for Medicare and Med-
icaid Services, 2002) to 88% (1). However, few studies have
evaluated either the prognostic value of EF obtained by gated
SPECT or other nonperfusion characteristics such as transient
ischemic dilation (TID) or resting left ventricular (LV) size
when assessed by these new 99mTc-labeled agents.
The aims of this study were, thus, threefold: 1) to
evaluate the prognostic value of MPI in the community
setting; 2) to determine the components of 99mTc-sestamibi
MPI that best predict outcome; and 3) to evaluate the
post-test utilization of cardiac catheterization and revascu-
larization after MPI performed in this nonacademic setting.
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METHODS
Study population. The study population consisted of
1,782 consecutive patients undergoing 99mTc-sestamibi
stress gated SPECT imaging between August 1997 and
March 1999 in the outpatient nuclear cardiology laboratory
of the 42-physician Mission Internal Medical Group in
Mission Viejo, California. During this period, 1,612 pa-
tients underwent 1,792 studies. All patients provided writ-
ten informed consent for MPI and long-term follow-up of
their health status, including permission to contact their
physicians and health care institutions to determine their
health status and to present the results of their study and
follow-up for scientific purposes.
Stress testing protocol. Exercise and pharmacologic test-
ing was physician supervised and performed within the
guidelines of the American College of Cardiology/American
Heart Association (8). Imaging was carried out within the
guidelines of the American Society of Nuclear Cardiology
(9). The method of stress was exercise in 63% of patients,
adenosine in 34%, and dobutamine in 3%. Exercise studies
were symptom-limited, with a goal of 85% maximum
predicted heart rate. Among patients undergoing adenosine
stress, 66% underwent simultaneous low-level treadmill
exercise during the 6-min adenosine infusion of 140 /kg/
min (termed “Adenoex”), as previously described (10).
Simultaneous treadmill exercise was not performed if the
patient was judged by the supervising physician to be
physically unable to walk for 6 min or if his/her resting
electrocardiogram (ECG) demonstrated left bundle branch
block or ventricular pacing.
SPECT protocol. Tomographic imaging was performed,
as described previously (10), with a single-head Seimens
ZLC 7500 Orbiter camera equipped with 75 photomulti-
plier tubes (Hoffman Estates, Illinois). A 180° arc was used
with 32 projections, 40 s per projection for 99mTc-sestamibi
and 45 s for 201Tl. Dual isotope imaging with resting 201Tl
and stress 99mTc-sestamibi was performed if the patient was
240 pounds, and two-day 99mTc-sestamibi imaging study
was used for patients of greater weight or challenging body
habitus. The SPECT imaging was performed with eight-
frame gating 15 to 60 min post stress. Images were
displayed using an 80  80 pixel matrix with acquisition
software authored by Lear (11) that included EF. Motion,
attenuation, and scatter correction and quantitative perfu-
sion or LV function algorithms were not available.
The technologist reviewed the raw data of each scan for
patient motion, and the processed images of each stress scan
for an inferior defect, to determine if a second, 8-min
non-gated SPECT scan should be performed. If motion
was judged to be2 pixels, a repeat non-gated SPECT scan
was performed. Additionally, if the technologist observed an
inferior defect on the stress images, the patient underwent a
non-gated SPECT scan in the prone position. In total, a
second post-stress SPECT scan was performed in 27% of
patients.
Image interpretation. Each study was interpreted by one
of two nuclear cardiologists certified by the Certification
Board of Nuclear Cardiology (G.S.T., M.I.M.) and in-
cluded an overall five-point global score of normal, probably
normal, equivocal, probably abnormal, or abnormal. A scan
was defined to be “abnormal” if either perfusion, LV
function, or LV size was abnormal. Expected abnormal
septal motion secondary to bundle branch block, ventricular
pacing, or after cardiac surgery was regarded as normal. For
the purposes of the prognostic component of this investi-
gation and as prospectively specified, scans interpreted as
normal, probably normal, or equivocal were grouped as
normal. Those scored as abnormal or probably abnormal
were grouped as abnormal. Only in evaluating the use of
post-test coronary angiography and revascularization was
the five-point scoring system retained. Left ventricular size
at rest was scored semi-quantitatively on a four-point scale
as normal or mildly, moderately, or severely enlarged.
Similarly, TID was described on a four-point scale as
absent, mild, moderate, or severe. Both resting LV size and
TID were assessed by visual evaluation. Interpreters “read
around” the expected difference in cavity size between the
two isotopes when dual isotope imaging was performed.
Representative examples of TID scoring as mild, moderate,
and severe with dual isotope imaging are shown in Figure 1.
Abbreviations and Acronyms
CABG  coronary artery bypass graft
CAD  coronary artery disease
ECG  electrocardiogram/electrocardiographic/
electrocardiography
EF  ejection fraction
LV  left ventricular
MI  myocardial infarction
MPI  myocardial perfusion imaging
PCI  percutaneous coronary intervention
SPECT  single photon emission computed tomography
TID  transient ischemic dilation
Figure 1. Representative examples of dual isotope imaging with mild (A),
moderate (B), and severe (C) transient ischemic dilation scoring.
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As would be expected in an office setting, clinical infor-
mation was often available to the interpreting nuclear
cardiologist. In 88% of cases, the interpreting cardiologist
was not the referring cardiologist.
Only qualitative perfusion information was entered in the
initial clinical MPI reports. Retrospectively, in order to
quantitatively assess the extent and severity of the stress
defect and the extent of reversibility, the two nuclear
cardiologists performed a blinded review of the qualitative
reports of all patients to provide a semi-quantitative score of
the extent and severity at stress and extent of reversibility.
The review was performed without knowledge of patient
identity, age, or clinical information. The extent and sever-
ity of observed perfusion defects were scored on a four-point
scale, based on their size and intensity described in the
initial report (Table 1A). Defect extent and severity ranged
from a score of 1 (small, mild-to-moderate intensity defect)
to a score of 4 (large, severe intensity defect). Where
multiple defects were observed, defect extent was deter-
mined by the sum of the size of all defects. A separate
reversibility (or ischemia) score was similarly assigned
(Table 1B). The reversibility score combined elements of
defect size with the absolute change in intensity of tracer
activity within the predominant defect between stress and
resting conditions. All fixed or predominantly fixed defects
were assigned a reversibility score of 0. Correspondingly,
large defects with a moderate-to-severe change in intensity
from stress to rest were assigned a reversibility score of 4.
To evaluate for the potential of the clinical information to
bias the interpretation of the initial study and to evaluate the
reproducibility of scan interpretation, we performed a
blinded re-review of the images of a random sample of 10%
of studies. Only patient size, gender, and type of test were
available during the blinded re-review, performed jointly by
the two nuclear cardiologists an average of four years after
the initial interpretation. No studies in the re-review were
excluded because of poor quality, or the presence of artifacts
such as those caused by patient motion, or gut overlap.
Concordance for the global score was 82% (133 of 162) with
a kappa value of 0.68 (p  0.0001). Corresponding kappa
values for extent and severity and reversibility scores were
both 0.4 (p  0.0001).
Follow-up and ascertainment of end points. Patients
were contacted an average of 24 7 months after testing. A
scripted phone interview was used to determine the clinical
status of each patient including the occurrence of myocar-
dial infarction (MI), coronary angiography, and revascular-
ization. The interviewer was blinded to the results of MPI.
If a patient could not be reached by phone, clinical status
was obtained by a letter to the patient or through a review
by an experienced RN or physician of the patient’s office or
hospital chart. In the case of death, information was
obtained from family members, medical records, the Social
Security Death Index, and death certificate, which was
obtained for all patients who died.
Cause of death was ascertained by review of the medical
record and death certificate by investigators blinded to the
results of MPI. Myocardial infarctions were confirmed by
death certificate or chart review requiring clinical symptoms
and cardiac enzyme elevation, either CPK-MB or troponin,
greater than the hospital upper limit of normal. Coronary
angiography and revascularization were confirmed by chart
review. To identify events that patients did not recall,
admissions to the major local hospital were searched for all
admissions by study patients over the study period. Finally,
the databases of the catheterization laboratories of the two
local hospitals performing angiography and revasculariza-
tion were searched for study patients, as was the Seattle
Systems Apollo database for the regional cardiac surgeons
(Bellevue, Washington).
Of the 1,612 patients, follow-up was obtained in 99.81%
(1,609 of 1,612 total patients). Mean follow-up of surviving
patients was 24  7 months, ranging from a minimum of
13 to a maximum of 36 months.
Statistical analysis. The primary end point for this analysis
was cardiac death or nonfatal MI. Comparisons of categor-
ical variables were completed using a chi-square statistic.
Continuous variables were compared for the occurrence of
cardiac events by one-way analysis of variance techniques.
Univariable and multivariable Cox proportional hazards
models were constructed to estimate cardiac death and MI.
In particular, we assessed the relationship of myocardial
perfusion and ventricular function data to the primary end
point in unadjusted and risk-adjusted survival analysis.
First-order interaction effects were tested for gender and the
type of stress performed in the prognostic analyses. Subset
analyses were performed using a stratified Cox proportional
hazard model. For risk-adjustment, a clinical pre-test like-
lihood hazard score was derived using age, gender, resting
normal or abnormal ECG, diabetes, hypertension, history
of coronary artery disease (CAD), history of smoking, and
family history of premature CAD. Survival curves were
developed using an SPSS 11.0 statistical software package
(Chicago, Illinois). For the survival analysis, patients under-
going coronary revascularization were included up until the
date of their procedure and censored thereafter. Reproduc-
Table 1. Semi-Quantitative Scores
A. Determination of Extent and Severity Score
Defect Size
Defect Intensity
Mild-to-Moderate Severe
Small 1 2
Moderate 2 3
Large 3 4
B. Determination of Reversibility Score
Defect Size
Change in Intensity
None Mild Moderate-to-Severe
Small 0 1 2
Moderate 0 2 3
Large 0 3 4
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ibility was assessed by means of percent agreement and the
Kappa statistic. Time to cardiac catheterization, percutane-
ous coronary intervention (PCI), and coronary artery bypass
graft surgery (CABG) were assessed using Cox proportional
hazard techniques.
RESULTS
Clinical characteristics and SPECT results. The average
age of the patients was 65  12 years, and 62% were
men (Table 2). Dual isotope rest 201Tl and stress
99mTc-sestamibi imaging was performed in 85% of patients.
Table 3 compares the imaging results of the 171 patients
who underwent revascularization within 60 days of MPI to
those who did not. Imaging parameters were more abnor-
mal in the early revascularization group for all characteristics
other than resting LV size.
Overall two-year event-free survival. Over the follow-up
period, 27 cardiac deaths and 62 MIs occurred, totaling 71
unique events. Unadjusted Cox death or MI-free survival at
two years was 97.3%, or an annualized event rate of 1.35%.
Cox survival analysis. Elderly, male patients who were
diabetic or past or current smokers had an increased rate of
cardiac death or nonfatal MI (Table 4). Among patients
with normal scans, event-free survival was 99.6% at one year
and 99.2% at two years. All events were nonfatal MI. For
those with abnormal scans, event-free survival at two years
was 95.4% (p  0.0001). Mean EF ( SD) was 58  11%
in those without events, compared with 51.3  12% for
those with events (p  0.0001).
Event-free survival based on the extent and severity of the
stress defect is shown in Figure 2A. Two-year survival for
patients with extent and severity scores of 0, 1, 2 to 3, and
4 was 99.0%, 97.0%, 95.3%, and 91.7%, respectively (p 
0.0001). Similarly, event-free survival corresponding to the
reversibility scores of 0 to 1, 2 to 3, and 4 was 98.6%, 96.0%,
and 91.3%, respectively (p  0.0001) (Fig. 2B).
Categorized by LV size at rest, patients with no, mild,
moderate, and severe LV enlargement experienced unad-
justed two-year survival rates of 97.0%, 96.7%, 92.0%, and
87.5%, respectively (p  0.012). Categorized by TID,
two-year event-free survival for those with none, mild, and
moderate-to-severe TID was 97.0%, 93.8%, and 88.0%,
respectively (p  0.0001) (Fig. 3A). Including only those
who underwent dual isotope imaging, those with none,
mild, and moderate-to-severe TID had event-free survival
rates of 99.0%, 95%, and 92.5%, respectively (p  0.0001)
(Fig. 3B). Transient ischemic dilation stratified patients
who underwent either exercise stress or adenosine stress
testing (p  0.0001) (Figs. 3C and 3D). Event-free survival
at two years was 99%, 96%, and 93.5% for exercising
patients with none, mild, and moderate-to-severe TID,
respectively. Similarly, for those undergoing adenosine
stress, overall survival was 97%, 93%, and 89% for none,
mild, and moderate-to-severe TID, respectively.
There was a significant interaction effect for the prognos-
tic value of TID and the type of stress performed. That is,
the relative risk of death or infarction in patients with TID
was greatest when it occurred with adenosine testing with
low-level exercise (relative risk 2.23-fold, 95% confidence
interval [CI]  1.5 to 3.4, p  0.0001), compared with the
borderline increase in risk seen when it occurred with
adenosine testing without exercise (relative risk  1.9, 95%
CI  0.98 to 3.7, p  0.055).
Event-free survival was directly related to post-stress EF
(Fig. 4A), such that event-free survival decreased from
99.0% to 87.0% with a decreasing post-stress EF of 70% to
20% (p  0.0001). Integrating function and perfusion,
Table 2. Clinical Characteristics and SPECT Results in
All Patients
Mean age, yrs  SD 65  12
Male gender, % 62
Abnormal rest ECG, % 65
Cardiac risk factors, %
Hypertension 50
Past or current smoker 56
Diabetes 14
Insulin-dependent 4
Hypercholesterolemia 54
Referral diagnosis*, %
Chest pain 29
Dyspnea or heart failure 8
Known coronary disease 53
Post-revascularization 31
Post-PCI 21
Post-CABG 13
Abnormal ECG 14
Test type, %
99mTc-sestamibi 15
Dual isotope rest 201T1/stress99mTc 85
Stress type, %
Adenosine 34
With exercise 23
Dobutamine 3
Exercise 63
85% Predicted maximum heart rate achieved, % 94
Resting left ventricular enlargement, %
Mild 5
Moderate 4
Severe 2
Global score, %
Normal 37
Abnormal 63
Extent and severity score, %
0 39
1 14
2–3 39
4 8
Reversibility score, %
0–1 59
2–3 28
4 13
Post-stress EF, % 58  11
Transient ischemic dilation, %
Mild 17
Moderate-to-severe 6
*Not exclusive
CABG  coronary bypass grafting; ECG  electrocardiogram; EF  ejection
fraction; PCI  coronary intervention; SPECT  single photon emission computed
tomography.
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overall event-free survival for patients in those with an EF
above or below 40%, with and without inducible ischemia,
is shown in Figure 4B and 4C. For those whose EF was
40%, the two-year event-free survival rate worsened from
97.8% to 92.0% with increasing ischemia. For those patients
with an EF 40%, survival worsened from 94.2% to 80.4%
with increasing ischemia. Similarly, in a stratified analysis of
patients with an EF50%, event-free survival was 98.5% in
those with a reversibility score of 0 to 1 compared with
93.7% in those with a reversibility score of 4 (p  0.012).
Among those with an EF 50%, event-free survival wors-
ened from 95.5% in those with reversibility scores of 0 to 1
compared with 86% in those with a score of 4 (p  0.012).
When analyzing patients by post-stress EF deciles of 40%
to 49% down to 20%, event-free survival ranged from
95.0% to 89.7% in those with ischemia (p  0.0001)
compared with 97.8% to 91% in those without ischemia
(p  0.0001).
Cox multivariable regression model. After adjusting for
age, gender, resting ECG, prior known CAD, cigarette
smoking, hypertension, hypercholesterolemia, diabetes, and
family history of CAD, the most important independent
prognostic variables, in order of importance, were: TID,
extent of reversibility, post-stress EF, extent and severity of
the stress perfusion defect, and the global score (Table 5).
For TID, the relative risk increased 3.3-fold for patients
with moderate-to-severe TID and 1.6-fold for patients with
mild TID (p  0.0002). For post-stress EF, each 1%
decrement in EF represented a 3% increase in risk (p 
0.0009).
Subset analyses. As detailed in Table 6, MPI predicted
outcome in the following key subsets: women and men,
diabetics, patients with known or suspected CAD, patients
referred for chest pain, those with prior abnormal exercise
ECGs, and those with normal or abnormal resting ECGs.
Among diabetics with abnormal studies, women experi-
enced a greater relative risk than men, 5.2 versus 2.7.
We also compared the event-free survival rates for those
undergoing exercise and adenosine stress testing. For those
undergoing exercise stress, normal and abnormal scans were
associated with annualized event rates of 0.4% and 2.2%,
respectively (p  0.0001). For those undergoing adenosine
stress without low-level exercise, annualized event rates
were 0.9% and 3.3% for those with normal and abnormal
scans, respectively (p  0.0001). For those undergoing
adenosine combined with low-level exercise (Adenoex),
normal and abnormal studies were associated with annual-
ized event rates of 1.1% and 4.7%, respectively (p 
Table 3. SPECT Results of Those Undergoing Early
Revascularization (60 Days) Versus Non-Early
Revascularization Patients
Early Revasc.
(<60 days), %
Non-Early
Revasc., % p Value
Global score 0.001
Normal 3 41
Abnormal 97 59
Post-stress EF  SD 54.2  11 58  11 0.001
Extent and severity score 0.001
0 4 43
1 11 14
2–3 75 35
4 9 7
Reversibility score 0.001
0–1 18 65
2–3 42 27
4 40 9
TID 0.001
Mild 31 16
Moderate-to-severe 25 5
Resting LV enlargement 0.63
Mild 7 6
Moderate 3 3
Severe 1 2
EF  ejection fraction; LV  left ventricular; Revasc.  revascularization; SPECT
 single photon emission computed tomography; TID  transient ischemic dilation.
Table 4. Unadjusted, Univariable Two-Year Cox Cardiac Death
or Myocardial Infarction-Free Survival by Clinical History
and SPECT
Death or Myocardial
Infarction-Free
Survival, % p Value
Age 0.006
65 yrs 96.7
65 yrs 94.0
Gender 0.001
Male 93.8
Female 98.0
Cardiac risk factors
Hypertension 94.2 0.039
Past or current smoker 89.0 0.005
Diabetes 90.4 0.003
Hypercholesterolemia 95.6 0.37
Referral diagnosis*
Chest pain 94.6 0.074
Known coronary disease 93.6 0.0001
Post-revascularization 93.6 0.0001
Abnormal noninvasive test 96.0 0.79
Resting electrocardiogram 0.003
Normal 97.6
Abnormal 94.0
Stress type 0.0001
Exercise 98.6
Adenosine 95.4
Adenosine with exercise 95.4
Global score 0.0001
Normal 99.2
Abnormal 95.4
Transient ischemic dilation 0.0001
None 97.0
Mild 93.8
Moderate-to-severe 88.0
Resting left ventricular size 0.012
Normal 97.0
Mild 96.7
Moderate 92.0
Severe 87.5
*Not exclusive
SPECT  single photon emission computed tomography.
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0.0001). In fact, a test for an interaction effect was signifi-
cant (chi-squared  22, p  0.0001), such that the overall
relative risk increased 3.91-fold (95% CI  2.3 to 6.7) for
an abnormal scan in patients who underwent Adenoex,
while the relative risk was only 3.2-fold higher (95% CI 
1.6 to 6.4) for an abnormal test result when adenosine was
infused without exercise.
Post-test use of cardiac catheterization and coronary
revascularization. During the study period, 499 patients
(31%) underwent coronary angiography, 252 (16%) under-
went PCI, and 105 (7%) underwent CABG (Table 7).
Catheterization was rarely performed in patients with nor-
mal scans: 2.0% at 90 days and 3.0% at the end of two years
(p  0.0001). Catheterization increased with increasing
ischemia, with 47.0% of those with reversibility scores of 4
undergoing angiography within 90 days and 67.0% within
two years (p  0.0001).
Coronary revascularization increased linearly with extent
of ischemia. Among those patients with normal scans, PCI
was performed in only 0.3% during the first 90 days and
1.0% by the end of two years (p  0.0001), while CABG
was performed in 0.4% and 0.7% over the same time
intervals (p  0.001). The highest rates of PCI (37% at two
years) and CABG (14.0% at two years) were seen in those
with the most ischemia, those with a reversibility score of 4.
As seen with reversibility, catheterization, PCI, and CABG
increased with increasing extent and severity of the stress
defect and with decreasing post-stress EF (p  0.0001)
(Table 7).
DISCUSSION
It is well established that MPI performed with 201Tl (3),
99mTc-sestamibi (5,6), and 99mTc-tetrofosmin (7) provides
important incremental prognostic information. Our study is
unique in that MPI was performed in the community, in a
physician’s office setting, while each of the previous studies
had been carried out in an academically based nuclear
cardiology/medicine program, with all except that of
O’Keefe et al. (12) being hospital based.
The 0.4% annual hard event rate in patients with normal
MPI found in this study parallels the rates of1% observed
in previous studies (5,13–15). This event rate in patients
with normal scans is lower than the rate for the general
population of the U.S. (5,16). The event rate for patients
with abnormal scans in our study, 2.3% per year, is lower
than observed in previous investigations. Corresponding
annual event rates in patients with abnormal scans were
3.5% to 7.1%, 5.4%, and 7.4% in studies by Hachamovitch
et al. (13), Boyne et al. (14), and Iskander et al. (5),
respectively. The difference is probably due to: 1) the
inclusion of inpatients in the previous studies; 2) the
increasing use of revascularization manifested by a 10.6%
rate of revascularization within the 60 days of MPI in our
contemporary study compared with 6.8% among patients in
the earlier Hachamovitch et al. study (13); 3) the ongoing
decrease in age-specific cardiac mortality occurring in the
U.S. (17); and 4) the increasing use of MPI that may have
resulted in lower risk individuals making up a greater
percentage of patients.
Multivariable analysis. After adjusting for clinical factors,
the most powerful components of MPI, in decreasing level
of prognostic significance, were: TID, defect reversibility,
post-stress EF, extent and severity of the stress defect, and
the global score.
The finding that TID adds powerful prognostic informa-
tion to dual isotope imaging, though not previously dem-
onstrated, is welcome given its long-established prognostic
value with 201Tl imaging (18) and the more recent dem-
onstration of its prediction of severe and extensive CAD
with dual isotope imaging (19). Challenges in the evalua-
tion of TID include the differing physical characteristics
of 99mTc-sestamibi and 201Tl and the necessary delay in
99mTc-sestamibi imaging after stress. Despite these issues,
we found that increasing degrees of TID predicted increas-
Figure 2. Cumulative two-year event-free survival stratified by defect extent and severity score (A) and reversibility score (B), p  0.001 for each.
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ing risk, and this was consistent across both exercise and
adenosine stress. As has been previously demonstrated (6),
we also found that increasing degrees of defect reversibility
and increasing extent and severity of the stress defect
provided substantial incremental prognostic value.
The availability of 99mTc perfusion agents provides the
opportunity to gate images and, thus, obtain a post-stress
EF, leading several authors to predict that this would offer
additional incremental prognostic value (6,20). This poten-
tial has only recently been evaluated. The work of Sharir et
al. (21) demonstrated that a gated SPECT post-stress EF of
45% was an independent predictor of cardiac events. In a
follow-up study of 2,686 patients, Sharir et al. (22) sepa-
rately evaluated the predictors of cardiac death and nonfatal
MI, finding that gated SPECT post-stress EF best pre-
dicted cardiac death, while ischemia best predicted nonfatal
MI. Kroll et al. (23) studied 120 inpatients after MI who
were treated medically and found that predischarge post-
stress gated SPECT EF provided incremental prognostic
benefit among patients with an EF of 40%. Our study
confirms and extends these findings; in particular, a 3%
increase in risk was observed for every 1% decrease in EF (p
 0.0009). In addition, we found that, despite adjustment
for EF, ischemia continued to provide incremental prog-
nostic information.
Reproducibility analysis. As typically occurs in the inter-
pretation of nuclear cardiology images, some clinical infor-
mation was available to the interpreting physicians for many
of the patients in this study. To evaluate the potential
influence of this information on scan interpretation, a
re-read of 10% of the studies was performed with the
interpreters blinded to clinical data. Agreement between the
initial interpretation of the global score and the blinded
re-read four years later was good, with 82% concordance
(K  0.68). This is comparable, though slightly less, than
the concordance rates in the intraobserver reproducibility
studies of Danias et al. (24), 83% to 88% (K 0.54 to 0.73),
and Golub et al. (25), 88% to 93% (K  0.76 to 0.87).
Although the impact of clinical information could have
resulted in the small difference in reproducibility between
Figure 3. Cumulative two-year event-free survival stratified by transient ischemic dilation for all patients (A), only those undergoing dual isotope imaging
(B), and those undergoing exercise (C) or adenosine (D) stress, p  0.0001 for each.
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the studies, other factors also are likely to have played a role.
The images interpreted for the study of Danias et al. (24)
were performed with the benefit of motion correction
software, while such software was not available in the
current study. In the study of Golub et al. (25), only studies
of “good-to-excellent” quality were selected for inclusion.
As well, Golub et al. (25) included only patients undergoing
exercise stress, 16% of whom were women. In the current
study, a random sample of all studies was interpreted in the
blinded re-read, including those of suboptimal quality. A
total of 37% were performed with pharmacologic stress,
with its increased potential for significant overlap of gastro-
intestinal contents, and 38% were performed in women, in
Figure 4. (A) Cumulative two-year event-free survival based on post-stress ejection fraction (EF), p  0.001. Dotted lines represent 95% confidence
intervals. Cumulative two-year event-free survival stratified by reversibility score in patients with EFs 40 (B) and 40% (C), p  0.001 for each.
Table 5. Risk-Adjusted* Multivariable Cox Model Estimating
Cardiac Death or Myocardial Infarction
Relative Risk 95% CI p Value
Transient ischemic dilation 1.63 1.20, 2.21 0.002
Reversibility score 1.58 1.16, 2.15 0.003
Post-stress ejection fraction 0.97 0.96, 0.99 0.009
Extent and severity score 1.37 1.03, 1.82 0.03
Global score 2.49 1.90, 3.26 0.03
*Controlling for age, gender, resting electrocardiography abnormalities, history of
coronary disease, current or past history of smoking, diabetes, and family history of
coronary disease.
CI  confidence interval.
Table 6. Annualized Cardiac Death or Nonfatal Myocardial
Infarction Rates for SPECT Results in Key Patient Subsets
SPECT
p ValueNormal, % Abnormal, %
Gender 0.0001
Women 0.4 1.8
Men 0.6 3.8
Diabetics 0.9 5.8 0.0001
History of coronary disease 1.1 4.0 0.001
Suspected coronary disease 0.5 2.2 0.001
Evaluation of chest pain 0.5 2.7 0.0001
Rest ECG 0.0001
Normal 0.3 1.7
Abnormal 0.9 5.3
Stress type 0.0001
Exercise 0.4 2.2
Adenosine with exercise 1.1 4.7
Adenosine alone 0.9 3.3
SPECT  single photon emission computed tomography.
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whom artifacts would be expected to be more frequent.
Given the results of our blinded re-review, the impact of
clinical data was probably small.
Adenosine stress. We observed, as previously described,
that patients referred for adenosine stress are at higher risk
for events than those referred for exercise stress and that
MPI can effectively stratify these patients (26–28). In
contrast with others, however, we had the opportunity to
specifically evaluate the prognostic value of the addition of
low-level treadmill exercise to adenosine. Analogous to
simultaneous semi-supine bicycle exercise pioneered by
Pennell et al. (29), the protocol has been found to be safe,
to improve image quality, and to decrease hypotensive and
arrhythmic side effects (10,29,30,31). More recently, Sa-
mady et al. (32) demonstrated an increase in the extent and
severity of reversible defects when simultaneous exercise at
the first two stages of the modified Bruce protocol was
combined with the standard adenosine infusion of 140
g/kg/min, compared with an adenosine infusion alone.
Annualized event rates for patients undergoing adenosine
infusion without simultaneous exercise in our study were
0.9% and 3.3% for those with normal and abnormal perfu-
sion scans, respectively (p  0.0001), compared with 1.1%
and 4.7% for those undergoing Adenoex (p  0.0001). The
difference in relative risks, 3.2 for adenosine alone and 3.91
for the combination, is significant (p  0.001), raising the
potential that the combination provides greater prognostic
value than adenosine alone. An alternative explanation,
however, is that the difference could have been caused by
unaccounted for differences in the populations undergoing
each test.
The presence of TID occurring with Adenoex also
provided further prognostic value compared with adenosine
alone, yielding relative risks of 2.23 for the combination and
1.9 for adenosine alone (p  0.001). These findings add
further evidence to the thesis that adenosine testing can be
enhanced by the addition of low-level exercise.
Diabetes. Our work provides further evidence that diabetes
itself is an incremental risk factor for cardiac events even
after allowing for the results of perfusion and function
imaging (28,33,34). However, as others have demonstrated,
MPI allowed substantial stratification among diabetics with
annualized event rates of 0.9% and 5.8% in patients with
normal and abnormal scans, respectively (p  0.0001). This
stratification is concordant to that found by Kang et al. (33)
who observed an annualized event rate in diabetics with
normal and abnormal MPI of 1.2% and 4% to 8%, respec-
tively, and that of Giri et al. (34).
Normal resting ECG. Myocardial perfusion imaging has
typically been reserved for patients with abnormal resting or
exercise ECGs or those requiring pharmacologic stress (8).
Hachamovitch et al. (35) recently demonstrated that MPI
provided incremental prognostic information in 3,058 con-
secutive patients with normal resting ECGs. They observed
an annual hard event rate of 0.4% among patients with
normal perfusion compared with 2.8% to 3.9% for those
with abnormal perfusion. We confirmed these findings in a
different cohort of patients with normal resting ECGs with
Table 7. Post-Test Use of Coronary Angiography, PCI, and CABG by SPECT Results*
Coronary
Angiography, % PCI, % CABG, %
2 years 90 days 2 years 90 days 2 years 90 days
Global score†
Normal 3.0 2.0 1.0 0.3 0.7 0.4
Probably normal 7.0 5.0 3.0 2.5 1.0 1.0
Equivocal 34.0 18.0 13.0 8.0 2.0 2.0
Probably abnormal 38.0 24.0 17.0 9.0 3.0 2.0
Abnormal 57.0 43.0 23.0 15.0 8.0 5.0
Reversibility score†
0–1 9.0 6.0 6.0 4.0 2.0 1.0
2–3 44.0 28.0 22.0 16.0 5.0 4.0
4 67.0 47.0 37.0 25.0 14.0 10.0
Extent and severity score†
0 7.0 5.0 3.0 2.0 2.0 1.0
1 36.0 24.0 18.0 13.0 5.0 3.0
2–3 44.0 32.0 20.0 15.0 8.0 5.0
4 47.0 34.0 22.0 18.0 13.0 9.0
Post-stress EF†
60% 15.0 10.0 7.0 5.0 0.0 0.0
50–59% 15.0 10.0 9.0 7.0 4.0 2.0
40–49% 33.0 25.0 13.0 11.0 6.0 5.0
30–39% 39.0 28.0 17.0 14.0 8.0 6.0
30% 45.0 24.0 24.0 17.0 12.0 8.0
*90-day and 2-year rates calculated using a Cox survival analysis using a time to cardiac procedure analysis; †p  0.0001.
CABG  coronary artery bypass grafting; EF  ejection fraction; PCI  percutaneous coronary intervention; SPECT 
single photon emission computed tomography.
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annualized event rates of 0.3% and 1.7% for those with
normal and abnormal scans, respectively (p  0.0001).
Gender. Women, constituting 38% of our cohort with an
average age of 66  11 compared with 64  12 years for
men, experienced lower annualized event rates than men but
were indeed stratified by perfusion imaging; women with
normal and abnormal SPECT scans had event rates of 0.4%
and 1.8%, respectively (p  0.0001). The effectiveness of
99mTc-based MPI in women is consistent with a large
earlier study of 1,394 women (36). The studies differed,
however, in the substantially higher event rates experienced
among women with abnormal SPECT scans in the previous
study (11.5%). The higher event rate observed in their
cohort may be explained by the inclusion of inpatients, the
aforementioned difference in time periods relative to less
frequent referral to revascularization (4.3% for women in the
previous study vs. 7.8% in our study), overall improvements
in cardiac care, and the increase in MPI usage.
Resource utilization after MPI. Although this study was
conducted in a physician’s office environment in which
economic incentives for self-referral to coronary angiogra-
phy would be expected to exist, clinicians effectively used
MPI as a “gatekeeper” to catheterization. The rate of
angiography for patients with normal studies, 2% at 90 days,
is similar to previous works in the academic setting. This
low rate held over two years with only an additional 1% of
patients undergoing catheterization by that time. This is
consistent with the only other study performed in what
could be regarded as a private practice setting, that of
Bateman et al. (37), in which the rate was similarly low:
3.5% over 8.9 months for patients with scans that were
either normal, equivocal, or had a nonreversible defect. We
found, as have others (4,28,38), that frequency of angiog-
raphy also increased in proportion to the amount of revers-
ibility. In addition, Shaw and others (4,28) have also
demonstrated that referral to revascularization increased
with increasing ischemia. We confirmed this finding but
also found revascularization to increase proportionally to
two other components of MPI found to add incremental
prognostic risk in our multivariate analysis, namely the
extent and severity of the stress defect and decreasing
post-stress EF. Although these latter findings are not
unexpected, they have not been previously demonstrated
and are consistent for the utilization of both PCI and
CABG, the frequency of each increasing linearly with
increasing reversibility, increasing extent and severity of the
stress defect, and with decreasing EF.
Health policy implications. Levin et al. (39) recently
challenged the justification for both the increasing rate of
referral of patients for MPI and the increasingly frequent
add-on measurement of EF by gated SPECT. Although
our study did not evaluate the appropriateness of referral to
MPI, it found the post-test use of MPI to be appropriate.
The low 2% rate of referral to catheterization within 90 days
and the appropriately increasing rate of referral to PCI and
CABG with increasing risk based on the results of MPI are
reassuring. We also found that the use of post-stress EF
added incremental prognostic information beyond that ob-
tained by perfusion alone.
Study limitations. The availability and use of clinical
information by the interpreting cardiologist could have
affected the interpretation of the MPI exam and, thus, its
prognostic significance. However, the high concordance and
kappa value between the initial clinical global score inter-
pretation and the blinded re-review four years later suggest
that any impact this may have had was small. As well, the
scoring of perfusion defect extent and severity and revers-
ibility was performed retrospectively from the image reports
rather than the images themselves. The use of a clinically
validated scoring system in real time would have been
preferred (9). Although the evaluation of TID was per-
formed in real time, it was performed visually rather than
quantitatively. The use of quantitative software for the
evaluation of LV volumes post stress and at rest may have
enhanced the assessment and reproducibility of TID. In
addition, in the evaluation of TID in the multivariable
analysis, both single and dual isotope studies were included
in the evaluation of the relative risk of TID.
Because the electrographic response to exercise or phar-
macologic stress was not prospectively catalogued, we were
unable to evaluate the value of the exercise ECG. However,
the resting ECG was abnormal in 65% of patients and 34%
of patients underwent adenosine stress, it is therefore
unlikely that this information would substantially impact
the results.
The use of a brief, second non-gated post-stress scan in
27% of our patients is atypical of community-based labora-
tories. Although currently available motion correction soft-
ware (40) generally obviates the need to rescan for patient
motion, this does not provide further evaluation of inferior
defects.
Conclusions. In sum, 99mTc-sestamibi-based MPI is trans-
ferable to community-based laboratories, and multiple com-
ponents of perfusion imaging provide incremental prognos-
tic information after multivariate adjustment for clinical
factors. These components include TID, defect reversibility,
post-stress EF, extent and severity of the stress defect, and
the global score. The incremental value of MPI is consistent
across all subgroups evaluated, including women, diabetics,
patients with normal resting ECGs, and those referred for
adenosine imaging, both with and without simultaneous
exercise. Use of post-test coronary angiography, PCI, and
CABG increased commensurate with increased prognostic
risk as assessed by MPI.
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